Showing results (1181-1190 of 1,797) with videos related to
Sort By:
Pageof 180
Mabs|December 20, 2014
Functional inhibition of β-catenin-mediated Wnt signaling by intracellular VHH antibodiesLaura E Newnham, Michael J Wright, Gill Holdsworth, et al.Mabs|December 20, 2014
Non-antigen-contacting region of an asymmetric bispecific antibody to factors IXa/X significantly affects factor VIII-mimetic activityZenjiro Sampei, Tomoyuki Igawa, Tetsuhiro Soeda, et al.Mabs|December 20, 2014
Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles--part 1: separation-based methodsDietmar Reusch, Markus Haberger, Bernd Maier, et al.Mabs|August 19, 2015
The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1βJean-Michel Rondeau, Paul Ramage, Mauro Zurini, et al.Mabs|October 3, 2015
Generation and preclinical characterization of an antibody specific for SEMA4DTerrence L Fisher, Christine A Reilly, Laurie A Winter, et al.Mabs|November 14, 2015
Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoformsDaniel Bedinger, Llewelyn Lao, Shireen Khan, et al.Mabs|October 23, 2015
Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell culturesKara S Cox, Aimin Tang, Zhifeng Chen, et al.Mabs|November 27, 2014
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env proteinFrançois Curtin, Hervé Perron, Arno Kromminga, et al.Mabs|November 27, 2014
Surrogate target cells expressing surface anti-idiotype antibody for the clinical evaluation of an internalizing CD22-specific antibodyShui-On Leung, Kai Gao, Guang Yu Wang, et al.Mabs|October 17, 2017
Personalized medicine with biologics for severe type 2 asthma: current status and future prospectsMarie Godar, Christophe Blanchetot, Hans de Haard, et al.Pageof 180